tixagevimab
Debugging in WordPress for more information. (This message was added in version 6.3.0.) in /home/biopharma/web/biopharma.media/public_html/wp-includes/functions.php on line 6078
Posted inCOVID-19, Infections, New Drugs, Regulatory

Pemgarda: For COVID-19 Protection Instead of Vaccines

Pemivibart every three months. For those who cannot receive the COVID-19 vaccine.

Debugging in WordPress for more information. (This message was added in version 6.3.0.) in /home/biopharma/web/biopharma.media/public_html/wp-includes/functions.php on line 6078
coronavirus Omicron
Posted inCOVID-19, Infections, Research

Omicron Treatment: Most Effective Drugs

Efficacy of antivirals and monoclonal antibodies for outpatient treatment of COVID-19 infection with the Omicron variant of SARS-CoV-2 coronavirus.

Debugging in WordPress for more information. (This message was added in version 6.3.0.) in /home/biopharma/web/biopharma.media/public_html/wp-includes/functions.php on line 6078
Posted inCOVID-19, Infections, New Drugs, Regulatory

Evusheld: First Drug for Strong and Long-Lasting Protection Against Coronavirus

One dose of AstraZeneca’s monoclonal antibody cocktail protects against COVID-19 for six months or longer.

Debugging in WordPress for more information. (This message was added in version 6.3.0.) in /home/biopharma/web/biopharma.media/public_html/wp-includes/functions.php on line 6078
coronavirus
Posted inCOVID-19, Infections, Research

Omicron Variant: Latest Scientific News, Findings, Evidence, and Developments

Up-to-date scientific information about the new Omicron variant of SARS-CoV-2/COVID-19.